Skip to main content

Advertisement

SpringerLink
Log in

Amyloid Beta Peptides Affect Pregnenolone and Pregnenolone Sulfate Levels in PC-12 and SH-SY5Y Cells Depending on Cholesterol

  • Original Paper
  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

Increased amyloid beta (AB) peptide concentration is one of the initiating factors in the neurodegeneration process. It has been suggested that cholesterol induces the synthesis of AB peptide from amyloid precursor protein or facilitates the formation of amyloid plaque by lowering the aggregation threshold of the peptide. It is also shown that AB peptides may affect cholesterol metabolism and the synthesis of steroid hormones such as progesterone and estradiol. Pregnenolone (P) and pregnenolone sulfate (PS) are the major steroids produced from cholesterol in neural tissue. In toxicity conditions, the effect of AB peptides on P and PS levels has not yet been determined. Furthermore, it has not been clearly defined how changes in cellular P and PS levels affect neuronal cell survival. The aim of this study was to determine the effects of AB peptides on cellular changes in P and PS levels depending on the level of their main precursor, cholesterol. Cholesterol and toxic concentrations of AB fragments (AB 25–35, AB 1–40 and AB 1–42) were applied to PC-12 and SH-SY5Y cells. Changes in cellular cholesterol, P and PS levels were determined simultaneously in a dose—and time-dependent manner. The cell viability and cell death types were also evaluated. AB peptides affected both cell viability and P/PS levels. Steroid levels were altered depending on AB fragment type and the cholesterol content of the cells. Treatment with each of the AB fragments alone increased P levels by twofold. However, combined treatment with AB peptides and cholesterol increased P levels by approximately sixfold, while PS levels were increased only about 2.5 fold in both cell lines. P levels in the groups treated with AB 25–35 were higher than those in AB 1–40 and AB 1–42 groups. The cell viabilities were significantly low in the group treated by AB and cholesterol (9 mM). The effect of AB peptides on P levels might be a result of cellular self-defense. On the other hand, the rate of P increase might be playing a key role in the cell death mechanism of AB toxicity depending on cellular cholesterol levels.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10

Similar content being viewed by others

References

  1. World Alzheimer Report (2014) Dementia and risk reduction. 2014. http://www.alz.co.uk/research/world-report-2014

  2. World Health Organization (Media centre) Dementia March 2015. http://www.who.int/mediacentre/factsheets/fs362/en/

  3. Zhu X, Perry G, Smith MA, Wang X (2013) Abnormal mitochondrial dynamics in the pathogenesis of Alzheimer’s disease. J Alzheimer’s Dis: JAD 33(Suppl 1):S253–S262

    PubMed  PubMed Central  Google Scholar 

  4. Nalivaeva NN, Turner AJ (2013) The amyloid precursor protein: a biochemical enigma in brain development, function and disease. FEBS Lett 587(13):2046–2054

    Article  CAS  PubMed  Google Scholar 

  5. De-Paula VJ, Radanovic M, Diniz BS, Forlenza OV (2012) Alzheimer’s disease. Sub-cell Biochem 65:329–352

    Article  CAS  Google Scholar 

  6. Gamblin TC, Chen F, Zambrano A, Abraha A, Lagalwar S, Guillozet AL et al (2003) Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer’s disease. Proc Natl Acad Sci USA 100(17):10032–10037

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297(5580):353–356

    Article  CAS  PubMed  Google Scholar 

  8. Ling Y, Morgan K, Kalsheker N (2003) Amyloid precursor protein (APP) and the biology of proteolytic processing: relevance to Alzheimer’s disease. Int J Biochem Cell Biol 35(11):1505–1535

    Article  CAS  PubMed  Google Scholar 

  9. Przedborski S, Vila M, Jackson-Lewis V (2003) Neurodegeneration: what is it and where are we? J Clin Investig 111(1):3–10

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Morley JE, Farr SA (2014) The role of amyloid-beta in the regulation of memory. Biochem Pharmacol 88(4):479–485

    Article  CAS  PubMed  Google Scholar 

  11. Finder VH, Glockshuber R (2007) Amyloid-beta aggregation. Neuro-degener Dis 4(1):13–27

    Article  CAS  Google Scholar 

  12. Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA 82(12):4245–4249

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Cole SL, Vassar R (2007) The Alzheimer’s disease beta-secretase enzyme, BACE1. Mol Neurodegener 2:22

    Article  PubMed  PubMed Central  Google Scholar 

  14. Evin G, Weidemann A (2002) Biogenesis and metabolism of Alzheimer’s disease Abeta amyloid peptides. Peptides 23(7):1285–1297

    Article  CAS  PubMed  Google Scholar 

  15. Simmons LK, May PC, Tomaselli KJ, Rydel RE, Fuson KS, Brigham EF et al (1994) Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro. Mol Pharmacol 45(3):373–379

    CAS  PubMed  Google Scholar 

  16. Wang R, Sweeney D, Gandy SE, Sisodia SS (1996) The profile of soluble amyloid beta protein in cultured cell media. Detection and quantification of amyloid beta protein and variants by immunoprecipitation-mass spectrometry. J Biol Chem 271(50):31894–31902

    Article  CAS  PubMed  Google Scholar 

  17. Yankner BA, Duffy LK, Kirschner DA (1990) Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. Science 250(4978):279–282

    Article  CAS  PubMed  Google Scholar 

  18. Lee SY, Lee JW, Lee H, Yoo HS, Yun YP, Oh KW et al (2005) Inhibitory effect of green tea extract on beta-amyloid-induced PC12 cell death by inhibition of the activation of NF-kappaB and ERK/p38 MAP kinase pathway through antioxidant mechanisms. Brain Res Mol Brain Res 140(1–2):45–54

    Article  CAS  PubMed  Google Scholar 

  19. Stepanichev MY, Moiseeva YV, Lazareva NA, Onufriev MV, Gulyaeva NV (2003) Single intracerebroventricular administration of amyloid-beta (25–35) peptide induces impairment in short-term rather than long-term memory in rats. Brain Res Bull 61(2):197–205

    Article  CAS  PubMed  Google Scholar 

  20. Stepanichev MY, Zdobnova IM, Zarubenko II, Moiseeva YV, Lazareva NA, Onufriev MV et al (2004) Amyloid-beta(25–35)-induced memory impairments correlate with cell loss in rat hippocampus. Physiol Behav 80(5):647–655

    Article  CAS  PubMed  Google Scholar 

  21. Stepanichev MY, Onufriev MV, Yakovlev AA, Khrenov AI, Peregud DI, Vorontsova ON et al (2008) Amyloid-beta (25-35) increases activity of neuronal NO-synthase in rat brain. Neurochem Int 52(6):1114–1124

    Article  CAS  PubMed  Google Scholar 

  22. Li G, Ma R, Huang C, Tang Q, Fu Q, Liu H et al (2008) Protective effect of erythropoietin on beta-amyloid-induced PC12 cell death through antioxidant mechanisms. Neurosci Lett 442(2):143–147

    Article  CAS  PubMed  Google Scholar 

  23. Schaeffer V, Meyer L, Patte-Mensah C, Eckert A, Mensah-Nyagan AG (2008) Dose-dependent and sequence-sensitive effects of amyloid-beta peptide on neurosteroidogenesis in human neuroblastoma cells. Neurochem Int 52(6):948–955

    Article  CAS  PubMed  Google Scholar 

  24. Brown RC, Cascio C, Papadopoulos V (2000) Pathways of neurosteroid biosynthesis in cell lines from human brain: regulation of dehydroepiandrosterone formation by oxidative stress and beta-amyloid peptide. J Neurochem 74(2):847–859

    Article  CAS  PubMed  Google Scholar 

  25. Pikuleva IA (2006) Cholesterol-metabolizing cytochromes P450. Drug Metab Dispos 34(4):513–520

    Article  CAS  PubMed  Google Scholar 

  26. Stefani M, Liguri G (2009) Cholesterol in Alzheimer’s disease: unresolved questions. Curr Alzheimer Res 6(1):15–29

    Article  CAS  PubMed  Google Scholar 

  27. Vallee M, Purdy RH, Mayo W, Koob GF, Le Moal M (2003) Neuroactive steroids: new biomarkers of cognitive aging. J Steroid Biochem Mol Biol 85(2–5):329–335

    Article  CAS  PubMed  Google Scholar 

  28. Herson PS, Koerner IP, Hurn PD (2009) Sex, sex steroids, and brain injury. Semin Reprod Med 27(3):229–239

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Mellon SH (2007) Neurosteroid regulation of central nervous system development. Pharmacol Ther 116(1):107–124

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Baulieu EE, Robel P, Schumacher M (2001) Neurosteroids: beginning of the story. Int Rev Neurobiol 46:1–32

    Article  CAS  PubMed  Google Scholar 

  31. Guarneri P, Cascio C, Russo D, D’Agostino S, Drago G, Galizzi G et al (2003) Neurosteroids in the retina: neurodegenerative and neuroprotective agents in retinal degeneration. Ann N Y Acad Sci 1007:117–128

    Article  CAS  PubMed  Google Scholar 

  32. Marx CE, Jarskog LF, Lauder JM, Gilmore JH, Lieberman JA, Morrow AL (2000) Neurosteroid modulation of embryonic neuronal survival in vitro following anoxia. Brain Res 871(1):104–112

    Article  CAS  PubMed  Google Scholar 

  33. Schaeffer V, Patte-Mensah C, Eckert A, Mensah-Nyagan AG (2008) Selective regulation of neurosteroid biosynthesis in human neuroblastoma cells under hydrogen peroxide-induced oxidative stress condition. Neuroscience 151(3):758–770

    Article  CAS  PubMed  Google Scholar 

  34. Charalampopoulos I, Remboutsika E, Margioris AN, Gravanis A (2008) Neurosteroids as modulators of neurogenesis and neuronal survival. Trends Endocrinol Metab 19(8):300–307

    Article  CAS  PubMed  Google Scholar 

  35. Guarneri P, Russo D, Cascio C, De Leo G, Piccoli F, Guarneri R (1998) Induction of neurosteroid synthesis by NMDA receptors in isolated rat retina: a potential early event in excitotoxicity. Eur J Neurosci 10(5):1752–1763

    Article  CAS  PubMed  Google Scholar 

  36. Akan P, Kizildag S, Ormen M, Genc S, Oktem MA, Fadiloglu M (2009) Pregnenolone protects the PC-12 cell line against amyloid beta peptide toxicity but its sulfate ester does not. Chem Biol Interact 177(1):65–70

    Article  CAS  PubMed  Google Scholar 

  37. Gursoy E, Cardounel A, Kalimi M (2001) Pregnenolone protects mouse hippocampal (HT-22) cells against glutamate and amyloid beta protein toxicity. Neurochem Res 26(1):15–21

    Article  CAS  PubMed  Google Scholar 

  38. Cascio C, Guarneri R, Russo D, De Leo G, Guarneri M, Piccoli F et al (2002) A caspase-3-dependent pathway is predominantly activated by the excitotoxin pregnenolone sulfate and requires early and late cytochrome c release and cell-specific caspase-2 activation in the retinal cell death. J Neurochem 83(6):1358–1371

    Article  CAS  PubMed  Google Scholar 

  39. Evans RM, Hui S, Perkins A, Lahiri DK, Poirier J, Farlow MR (2004) Cholesterol and APOE genotype interact to influence Alzheimer disease progression. Neurology 62(10):1869–1871

    Article  CAS  PubMed  Google Scholar 

  40. Puglielli L, Tanzi RE, Kovacs DM (2003) Alzheimer’s disease: the cholesterol connection. Nat Neurosci 6(4):345–351

    Article  CAS  PubMed  Google Scholar 

  41. Hall JR, Wiechmann AR, Johnson LA, Edwards M, Barber RC, Cunningham R et al (2014) Total cholesterol and neuropsychiatric symptoms in Alzheimer’s disease: the impact of total cholesterol level and gender. Dement Geriatr Cogn Disord 38(5–6):300–309

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Reiman EM, Chen K, Langbaum JB, Lee W, Reschke C, Bandy D et al (2010) Higher serum total cholesterol levels in late middle age are associated with glucose hypometabolism in brain regions affected by Alzheimer’s disease and normal aging. NeuroImage 49(1):169–176

    Article  CAS  PubMed  Google Scholar 

  43. Shepardson NE, Shankar GM, Selkoe DJ (2011) Cholesterol level and statin use in Alzheimer disease: II. Review of human trials and recommendations. Arch Neurol 68(11):1385–1392

    Article  PubMed  PubMed Central  Google Scholar 

  44. Prasanthi JR, Huls A, Thomasson S, Thompson A, Schommer E, Ghribi O (2009) Differential effects of 24-hydroxycholesterol and 27-hydroxycholesterol on beta-amyloid precursor protein levels and processing in human neuroblastoma SH-SY5Y cells. Mol Neurodegener 4:1

    Article  PubMed  PubMed Central  Google Scholar 

  45. Colell A, Fernandez A, Fernandez-Checa JC (2009) Mitochondria, cholesterol and amyloid beta peptide: a dangerous trio in Alzheimer disease. J Bioenerg Biomembr 41(5):417–423

    Article  CAS  PubMed  Google Scholar 

  46. Prasanthi RPJ, Schommer E, Thomasson S, Thompson A, Feist G, Ghribi O (2008) Regulation of beta-amyloid levels in the brain of cholesterol-fed rabbit, a model system for sporadic Alzheimer’s disease. Mech Ageing Dev 129(11):649–655

    Article  CAS  PubMed Central  Google Scholar 

  47. Di Scala C, Chahinian H, Yahi N, Garmy N, Fantini J (2014) Interaction of Alzheimer’s beta-amyloid peptides with cholesterol: mechanistic insights into amyloid pore formation. Biochemistry 53(28):4489–4502

    Article  PubMed  Google Scholar 

  48. Cossec JC, Marquer C, Panchal M, Lazar AN, Duyckaerts C, Potier MC (2010) Cholesterol changes in Alzheimer’s disease: methods of analysis and impact on the formation of enlarged endosomes. Biochim Biophys Acta 1801(8):839–845

    Article  CAS  PubMed  Google Scholar 

  49. Tillement JP, Lecanu L, Papadopoulos V (2010) Amyloidosis and neurodegenerative diseases: current treatments and new pharmacological options. Pharmacology 85(1):1–17

    Article  CAS  PubMed  Google Scholar 

  50. Bodovitz S, Klein WL (1996) Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein. J Biol Chem 271(8):4436–4440

    Article  CAS  PubMed  Google Scholar 

  51. Guarneri P, Cascio C, Piccoli T, Piccoli F, Guarneri R (2000) Human neuroblastoma SH-SY5Y cell line: neurosteroid-producing cell line relying on cytoskeletal organization. J Neurosci Res 60(5):656–665

    Article  CAS  PubMed  Google Scholar 

  52. Mruthinti S, Capito N, Sood A, Buccafusc JJ (2007) Cytotoxicity of Abeta1-42, RAGE23-54, and an Abeta-RAGE complex in PC-12 cells. Curr Alzheimer Res 4(5):581–586

    Article  CAS  PubMed  Google Scholar 

  53. Schaeffer V, Patte-Mensah C, Eckert A, Mensah-Nyagan AG (2006) Modulation of neurosteroid production in human neuroblastoma cells by Alzheimer’s disease key proteins. J Neurobiol 66(8):868–881

    Article  CAS  PubMed  Google Scholar 

  54. Zhou YQ, Yang ZL, Xu L, Li P, Hu YZ (2009) Akebia saponin D, a saponin component from Dipsacus asper Wall, protects PC 12 cells against amyloid-beta induced cytotoxicity. Cell Biol Int 33(10):1102–1110

    Article  CAS  PubMed  Google Scholar 

  55. Portelius E, Zetterberg H, Gobom J, Andreasson U, Blennow K (2008) Targeted proteomics in Alzheimer’s disease: focus on amyloid-beta. Expert Rev Proteomics 5(2):225–237

    Article  CAS  PubMed  Google Scholar 

  56. Irie K, Murakami K, Masuda Y, Morimoto A, Ohigashi H, Ohashi R et al (2005) Structure of beta-amyloid fibrils and its relevance to their neurotoxicity: implications for the pathogenesis of Alzheimer’s disease. J Biosci Bioeng 99(5):437–447

    Article  CAS  PubMed  Google Scholar 

  57. Calan OG, Akan P, Bagriyanik HA, Fadiloglu M (2014) The assessment of vital responses of human and rat neuronal cells against to amyloid beta peptide and neuroactive steroid treatment. J Neurol Sci Turk 31(1):28–39

    Google Scholar 

  58. Runz H, Rietdorf J, Tomic I, de Bernard M, Beyreuther K, Pepperkok R et al (2002) Inhibition of intracellular cholesterol transport alters presenilin localization and amyloid precursor protein processing in neuronal cells. J Neurosci 22(5):1679–1689

    CAS  PubMed  Google Scholar 

  59. Schumacher M, Liere P, Akwa Y, Rajkowski K, Griffiths W, Bodin K et al (2008) Pregnenolone sulfate in the brain: a controversial neurosteroid. Neurochem Int 52(4–5):522–540

    Article  CAS  PubMed  Google Scholar 

  60. Semeniuk T, Jhangri GS, Le Melledo JM (2001) Neuroactive steroid levels in patients with generalized anxiety disorder. J Neuropsychiatry Clin Neurosci 13(3):396–398

    Article  CAS  PubMed  Google Scholar 

  61. Fernandez A, Llacuna L, Fernandez-Checa JC, Colell A (2009) Mitochondrial cholesterol loading exacerbates amyloid beta peptide-induced inflammation and neurotoxicity. J Neurosci 29(20):6394–6405

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Gamble W, Vaughan M, Kruth HS, Avigan J (1978) Procedure for determination of free and total cholesterol in micro- or nanogram amounts suitable for studies with cultured cells. J Lipid Res 19(8):1068–1070

    CAS  PubMed  Google Scholar 

  63. Tagawa N, Nakata Y, Kusuda S, Kobayashi Y, Watanabe F (1997) Serum levels of 16-dehydropregnenolone sulfate during the early neonatal period. Biol Pharm Bull 20(1):76–78

    Article  CAS  PubMed  Google Scholar 

  64. Tagawa N, Tamanaka J, Fujinami A, Kobayashi Y, Takano T, Fukata S et al (2000) Serum dehydroepiandrosterone, dehydroepiandrosterone sulfate, and pregnenolone sulfate concentrations in patients with hyperthyroidism and hypothyroidism. Clin Chem 46(4):523–528

    CAS  PubMed  Google Scholar 

  65. Beaujean D, Mensah-Nyagan AG, Do-Rego JL, Luu-The V, Pelletier G, Vaudry H (1999) Immunocytochemical localization and biological activity of hydroxysteroid sulfotransferase in the frog brain. J Neurochem 72(2):848–857

    Article  CAS  PubMed  Google Scholar 

  66. Shirakawa H, Katsuki H, Kume T, Kaneko S, Akaike A (2006) Aminoglutethimide prevents excitotoxic and ischemic injuries in cortical neurons. Br J Pharmacol 147(7):729–736

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Zhu TS, Glaser M (2008) Regulatory role of cytochrome P450scc and pregnenolone in myelination by rat Schwann cells. Mol Cell Biochem 313(1–2):79–89

    Article  CAS  PubMed  Google Scholar 

  68. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65(1–2):55–63

    Article  CAS  PubMed  Google Scholar 

  69. Lobner D (2000) Comparison of the LDH and MTT assays for quantifying cell death: validity for neuronal apoptosis? J Neurosci Methods 96(2):147–152

    Article  CAS  PubMed  Google Scholar 

  70. van Engeland M, Nieland LJ, Ramaekers FC, Schutte B, Reutelingsperger CP (1998) Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 31(1):1–9

    Article  PubMed  Google Scholar 

  71. Westerink RH, Ewing AG (2008) The PC12 cell as model for neurosecretion. Acta Physiol 192(2):273–285

    Article  CAS  Google Scholar 

  72. Baulieu EE (1998) Neurosteroids: a novel function of the brain. Psychoneuroendocrinology. 23(8):963–987

    Article  CAS  PubMed  Google Scholar 

  73. Wang M (2011) Neurosteroids and GABA-a receptor function. Front Endocrinol 2:44

    Article  Google Scholar 

  74. Weill-Engerer S, David JP, Sazdovitch V, Liere P, Eychenne B, Pianos A et al (2002) Neurosteroid quantification in human brain regions: comparison between Alzheimer’s and nondemented patients. J Clin Endocrinol Metab 87(11):5138–5143

    Article  CAS  PubMed  Google Scholar 

  75. Refolo LM, Malester B, LaFrancois J, Bryant-Thomas T, Wang R, Tint GS et al (2000) Hypercholesterolemia accelerates the Alzheimer’s amyloid pathology in a transgenic mouse model. Neurobiol Dis 7(4):321–331

    Article  CAS  PubMed  Google Scholar 

  76. Kohjitani A, Fuda H, Hanyu O, Strott CA (2008) Regulation of SULT2B1a (pregnenolone sulfotransferase) expression in rat C6 glioma cells: relevance of AMPA receptor-mediated NO signaling. Neurosci Lett 430(1):75–80

    Article  CAS  PubMed  Google Scholar 

  77. Plassart-Schiess E, Baulieu EE (2001) Neurosteroids: recent findings. Brain Res Brain Res Rev 37(1–3):133–140

    Article  CAS  PubMed  Google Scholar 

  78. Stoffel-Wagner B (2001) Neurosteroid metabolism in the human brain. Eur J Endocrinol 145(6):669–679

    Article  CAS  PubMed  Google Scholar 

  79. Guarneri P, Russo D, Cascio C, De Leo G, Piccoli T, Sciuto V et al (1998) Pregnenolone sulfate modulates NMDA receptors, inducing and potentiating acute excitotoxicity in isolated retina. J Neurosci Res 54(6):787–797

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by The Scientific and Technological Research Council of Turkey (TUBİTAK 1001 Research Project No: 110S412).

Author information

Authors and Affiliations

  1. Department of Medical Biochemistry, Medical Faculty, Dokuz Eylul University, Izmir, Turkey

    Ozlem Gursoy Calan, Pinar Akan, Aysenur Cataler & Semra Kocturk

  2. Department of Neuroscience, Health Science Institute, Dokuz Eylul University, Izmir, Turkey

    Pinar Akan & Cumhur Dogan

Authors
  1. Ozlem Gursoy Calan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pinar Akan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Aysenur Cataler
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Cumhur Dogan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Semra Kocturk
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ozlem Gursoy Calan.

Ethics declarations

Conflict of interest

The authors have no conflict of interest to declare.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Calan, O.G., Akan, P., Cataler, A. et al. Amyloid Beta Peptides Affect Pregnenolone and Pregnenolone Sulfate Levels in PC-12 and SH-SY5Y Cells Depending on Cholesterol. Neurochem Res 41, 1700–1712 (2016). https://doi.org/10.1007/s11064-016-1886-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11064-016-1886-0

Keywords

Search

Navigation